Sort
30,917 grants matching “tumor microenvironment”
Project 1: Patterned Heterogeneity in Colon Cancer
$404,554Marian L Waterman · University Of California-Irvine · U54 · FY2020 · CA
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
$404,553Mark W Jackson · Case Western Reserve University · R01 · FY2022 · CA
Targeting Oncostatin M-Receptor to Suppress Metastasis and Therapy Failure
$404,553Mark W Jackson · Case Western Reserve University · R01 · FY2023 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$404,550Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
$404,530Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
A Novel Plasminogen Receptor in Breast Cancer
$404,465Barbara M Mueller · San Diego Biomedical Research Institute · R01 · FY2016 · CA
A Novel Plasminogen Receptor in Breast Cancer
$404,465Barbara M Mueller · San Diego Biomedical Research Institute · R01 · FY2015 · CA
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
$404,457Ralph R Weichselbaum · University Of Chicago · R01 · FY2023 · CA
Elucidating the Roles of RNA m6A readers Y1 and Y2 in radiation-induced immunity and immunotherapy
$404,457Ralph R Weichselbaum · University Of Chicago · R01 · FY2022 · CA
Identifying and Targeting Metabolic Dependencies in the Pancreatic Tumor Microenvironment
$404,377Mara H. Sherman · Oregon Health & Science University · R01 · FY2020 · CA
The lymph node microenvionment in tumor metastasis
$404,369Judith A. Varner · University Of California, San Diego · R01 · FY2010 · CA
Delineating the mechanisms of filopodia-mediated intracellular delivery of siRNAs via peptide carriers towards the development of a molecular targeted therapy for oral cancer
$404,132Andrew George Jakymiw · Medical University Of South Carolina · R21 · FY2024 · DE
Development of IDO PET agents for immunotherapy
$404,087Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Development of IDO PET agents for immunotherapy
$404,087Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
Development of IDO PET agents for immunotherapy
$404,087Zibo Li · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Macrophage polarization in glioma microenvironment
$404,063Yi Fan · University Of Pennsylvania · R01 · FY2022 · NS
Macrophage polarization in glioma microenvironment
$404,063Yi Fan · University Of Pennsylvania · R01 · FY2020 · NS
Macrophage polarization in glioma microenvironment
$404,063Yi Fan · University Of Pennsylvania · R01 · FY2019 · NS
Macrophage polarization in glioma microenvironment
$404,063Yi Fan · University Of Pennsylvania · R01 · FY2021 · NS
Targeting the dependency of cancer cells on the sirtuin SIRT5
$404,062Robert S Weiss · Cornell University · R01 · FY2023 · CA
Targeting the dependency of cancer cells on the sirtuin SIRT5
$404,056Robert S Weiss · Cornell University · R01 · FY2022 · CA
Role of Desmoglein 1 in Keratinocyte-Melanocyte Communication and Melanoma
$404,020Kathleen Janee Green · Northwestern University At Chicago · R01 · FY2020 · CA
Targeting MUC1-induced Tumor-stromal Metabolic Cross-talk in Pancreatic Cancer
$403,980Pankaj Kumar Singh · University Of Nebraska Medical Center · R01 · FY2014 · CA
Role of GATA3 in transcriptional pathways suppressing breast cancer metastasis
$403,939Zena Werb · University Of California, San Francisco · R01 · FY2018 · CA
Role of GATA3 in transcriptional pathways suppressing breast cancer metastasis
$403,939Zena Werb · University Of California, San Francisco · R01 · FY2016 · CA